Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of BRCA1/2 Mutation in High-Grade Non-Mucinous Ovarian Carcinoma.

Asian Pacific journal of cancer prevention : APJCP - 1 Nov 2025

Christianto Maria Angeline, Ariani Grace

Abstract excerpt

OBJECTIVE: Ovarian cancer is the third most common cancer among women with the most common subtype being high-grade ovarian carcinoma (90%), characterized by high genomic instability and somatic loss-of-function variants in BRCA1/2 genes. BRCA testing in patients with Epithelial Ovarian Cancer (EOC) is recommended because of its role in genome counseling, as well as enabling therapeutics. This study aimed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Follow-Up Studies

Share to Neoplasm Grading

Share to Ovarian Neoplasms

Share to Prevalence

Source

Open in PubMed Open full text

Identifiers

PMID: 41312946
DOI: 10.31557/APJCP.2025.26.11.4179
PMCID: PMC12948319

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of BRCA1/2 Mutation in High-Grade Non-Mucinous Ovarian Carcinoma.PMID 41312946Read ↗

Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study.Semantic proximity Read ↗

Rethinking ovarian cancer III: the past decade and future directions.Semantic proximity Read ↗

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.Semantic proximity Read ↗

BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report.Semantic proximity Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

Analysis and comparison of BRCA1/2 gene mutations in 310 cases of ovarian cancerSemantic proximity Read ↗

Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort.Semantic proximity Read ↗

The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patients.Semantic proximity Read ↗

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO GuidelineSemantic proximity Read ↗

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.Semantic proximity Read ↗

The Impact of Pathogenic BRCA1/2 Tumor Mutation Status on Advanced Stage-High Grade Serous Epithelial Ovarian Cancer Survival OutcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.